Takeda invests $14M to expand first ‘Zero Carbon Emissions’ biotech unit

Japanese firm Takeda Pharmaceutical building is preparing to follow the Singapore Green Mark Zero Energy certification scheme first within the company’s global manufacturing and supply network. Takeda is injecting $14 million in the expansion of manufacturing operations in Singapore. The endeavour is the first ‘net zero carbon emissions’ building in its global network and a firstof-its-kind investment within the biotechnology industry in Singapore. Located next to Takeda’s biologics manufacturing plant in JTC’s 60-hectare Woodlands Wafer Fab Park, Takeda’s new zero energy building is planned for occupancy by 2022. The building follows standards from the Singapore Building Construction Authority’s (BCA) Green Mark (GM) certification scheme and sets the bar for green energy design. The approval processes include the design, piling, construction, occupation and completion phases. The 60-hectare Woodlands Wafer

Fab Park caters to the stringent operating requirements of the global semiconductor and biomedical firms.